LONDON — Google announced on Tuesday a partnership with the European drug maker Novartis to develop a smart contact lens with the potential to monitor the wearer’s blood sugar levels.
The agreement is among recent moves into the health care sector by technology giants including Apple and Samsung as they develop devices and mobile applications to track people’s daily lives.
Novartis said that Alcon, its eye care unit, had struck a deal to license so-called smart lens technology from one of Google’s research divisions. Financial terms were not disclosed.
http://www.nytimes.com/2014/07/16/